Association of tamoxifen resistance and lipid reprogramming in breast cancer.
S. Hultsch, M. Kankainen, L. Paavolainen, R.-M. Kovanen, E. Ikonen, S. Kangaspeska, V. Pietiaeinen, O. Kallioniemi
This study identifies lipid reprogramming and lysosomal membrane permeabilization (LMP) prevention as key mechanisms of tamoxifen resistance in breast cancer, suggesting new therapeutic targets.
bioRxiv · Jun 25, 2018Cancer Biology